肿瘤细胞减灭术后的腹腔内化疗是否有效？知道其是否有效似乎并不重要！ - Suppr | 超能文献

Is intraperitoneal chemotherapy after cytoreductive surgery efficient? Knowing whether it is or not appears secondary!

作者信息

Elias Dominique

出版信息

Ann Surg Oncol. 2012 Jan;19(1):5-6. doi: 10.1245/s10434-011-1897-7.

DOI:10.1245/s10434-011-1897-7

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is intraperitoneal chemotherapy after cytoreductive surgery efficient? Knowing whether it is or not appears secondary!肿瘤细胞减灭术后的腹腔内化疗是否有效？知道其是否有效似乎并不重要！

Ann Surg Oncol. 2012 Jan;19(1):5-6. doi: 10.1245/s10434-011-1897-7.

2

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.细胞减灭术和腹腔内热灌注化疗联合全身化疗与单纯全身化疗治疗结直肠腹膜转移癌的比较。

Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.

3

Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.基于培美曲塞的全身联合化疗与肿瘤细胞减灭术及腹腔内热灌注顺铂和阿霉素对恶性腹膜间皮瘤生存影响的比较结果

Lung Cancer. 2009 Nov;66(2):269-70. doi: 10.1016/j.lungcan.2009.08.007. Epub 2009 Sep 4.

4

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.通过细胞减灭术联合围手术期腹腔内化疗治疗非卵巢来源腹膜癌病的治疗方法：一项对 1290 例患者的多机构研究。

Cancer. 2010 Dec 15;116(24):5608-18. doi: 10.1002/cncr.25356. Epub 2010 Aug 24.

5

Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.对细胞减灭术和围手术期腹腔内化疗治疗假性黏液瘤腹膜后并发症的危险因素的批判性评估。

Ann Surg Oncol. 2010 May;17(5):1291-301. doi: 10.1245/s10434-009-0875-9. Epub 2009 Dec 29.

6

The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.针对孤立性腹膜复发的完全细胞减灭术与腹腔内化疗联合的第二种手术方法：术后病程及长期预后

Ann Surg Oncol. 2009 Oct;16(10):2744-51. doi: 10.1245/s10434-009-0611-5. Epub 2009 Jul 21.

7

Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.细胞减灭术（CS）及腹腔内热灌注化疗（HIPEC）治疗腹膜表面恶性肿瘤：一项II期临床研究报告

In Vivo. 2009 Jul-Aug;23(4):645-7.

8

Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.减瘤手术联合术后早期腹腔内化疗治疗腹膜假黏液瘤后的生活质量：一项前瞻性研究

Dis Colon Rectum. 2008 Jun;51(6):868-74. doi: 10.1007/s10350-008-9223-6. Epub 2008 Feb 23.

9

[New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].[结直肠癌腹膜癌转移的新治疗方法。细胞减灭术和腹腔内热灌注化疗]

Ugeskr Laeger. 2007 Sep 17;169(38):3179-81.

10

[Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].[通过广泛的细胞减灭术联合术中腹腔内热化疗治疗结直肠癌和阑尾癌所致的腹膜癌病]

Rev Med Brux. 2005 Sep-Oct;26(5):439-44.

引用本文的文献

1

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.比较使用 212Pb 的α放射性免疫治疗小体积腹膜癌病时，内化抗 HER2 mAbs 和非内化抗 CEA mAbs 的效果。

PLoS One. 2013 Jul 29;8(7):e69613. doi: 10.1371/journal.pone.0069613. Print 2013.